BIRC5 and neoplasm: T-cell responses to tumor-associated antigens, particularly those specific for the so-called universal tumor associated antigens (TAAs) survivin and telomerase, may be detected in the blood of patients with various types of cancer, even in early phases of the disease (30–33).